<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">80854</article-id><article-id pub-id-type="doi">10.7554/eLife.80854</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>MLL3 regulates the <italic>CDKN2A</italic> tumor suppressor locus in liver cancer</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-284218"><name><surname>Zhu</surname><given-names>Changyu</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3583-3638</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-284217"><name><surname>Soto-Feliciano</surname><given-names>Yadira M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8523-7917</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284219"><name><surname>Morris</surname><given-names>John P</given-names><suffix>4th</suffix></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284220"><name><surname>Huang</surname><given-names>Chun-Hao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-54520"><name><surname>Koche</surname><given-names>Richard P</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6820-5083</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284221"><name><surname>Ho</surname><given-names>Yu-jui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284222"><name><surname>Banito</surname><given-names>Ana</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2188-0003</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-216137"><name><surname>Chen</surname><given-names>Chun-Wei (David)</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8737-6830</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284223"><name><surname>Shroff</surname><given-names>Aditya</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284224"><name><surname>Tian</surname><given-names>Sha</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-105370"><name><surname>Livshits</surname><given-names>Geulah</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284225"><name><surname>Chen</surname><given-names>Chi-Chao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284226"><name><surname>Fennell</surname><given-names>Myles</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-119628"><name><surname>Armstrong</surname><given-names>Scott A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9099-4728</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-1758"><name><surname>Allis</surname><given-names>C David</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-284216"><name><surname>Tschaharganeh</surname><given-names>Darjus F</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-5439"><name><surname>Lowe</surname><given-names>Scott W</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5284-9650</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">Department of Cancer Biology and Genetics</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Koch Institute for Integrative Cancer Research</institution>, <institution>Massachusetts Institute of Technology</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Pharmacology</institution>, <institution>The University of North Carolina at Chapel Hill</institution>, <addr-line><named-content content-type="city">Chapel Hill</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Center for Epigenetics Research</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Department of Pediatric Oncology</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Laboratory of Chromatin Biology and Epigenetics</institution>, <institution>The Rockefeller University</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution>German Cancer Research Center</institution>, <addr-line><named-content content-type="city">Heidelberg</named-content></addr-line>, <country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-5368"><name><surname>Zhu</surname><given-names>Hao</given-names></name><role>Reviewing editor</role><aff><institution>University of Texas Southwestern Medical Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>ysoto@mit.edu</email> (YS);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>d.tschaharganeh@dkfz.de</email> (DT);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>lowes@mskcc.org</email> (SL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>01</day><month>06</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e80854</elocation-id><history><date date-type="received"><day>07</day><month>06</month><year>2022</year></date><date date-type="accepted"><day>31</day><month>05</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Zhu et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Zhu et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-80854-v1.pdf"/><abstract><p>Mutations in genes encoding components of chromatin modifying and remodeling complexes are among the most frequently observed somatic events in human cancers. For example, missense and nonsense mutations targeting the mixed lineage leukemia family member 3 (MLL3, encoded by <italic>KMT2C</italic>) histone methyltransferase occur in a range of solid tumors, and heterozygous deletions encompassing <italic>KMT2C</italic> occur in a subset of aggressive leukemias. Although MLL3 loss can promote tumorigenesis in mice, the molecular targets and biological processes by which MLL3 suppresses tumorigenesis remain poorly characterized. Here we combined genetic, epigenomic, and animal modeling approaches to demonstrate that one of the mechanisms by which MLL3 links chromatin remodeling to tumor suppression is by co-activating the <italic>Cdkn2a</italic> tumor suppressor locus. Disruption of <italic>Kmt2c</italic> cooperates with <italic>Myc</italic> overexpression in the development of murine hepatocellular carcinoma (HCC), in which MLL3 binding to the <italic>Cdkn2a</italic> locus is blunted, resulting in reduced H3K4 methylation and low expression levels of the locus-encoded tumor suppressors p16/Ink4a and p19/Arf. Conversely, elevated <italic>KMT2C</italic> expression increases its binding to the <italic>CDKN2A</italic> locus and co-activates gene transcription. Endogenous <italic>Kmt2c</italic> restoration reverses these chromatin and transcriptional effects and triggers Ink4a/Arf-dependent apoptosis. Underscoring the human relevance of this epistasis, we found that genomic alterations in <italic>KMT2C</italic> and <italic>CDKN2A</italic> were associated with similar transcriptional profiles in human HCC samples. These results collectively point to a new mechanism for disrupting <italic>CDKN2A</italic> activity during cancer development and, in doing so, link MLL3 to an established tumor suppressor network.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>P01 CA013106</award-id><principal-award-recipient><name><surname>Lowe</surname><given-names>Scott W</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R01 CA233944</award-id><principal-award-recipient><name><surname>Lowe</surname><given-names>Scott W</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>1K99GM140265-01</award-id><principal-award-recipient><name><surname>Soto-Feliciano</surname><given-names>Yadira M</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>1F32CA257103</award-id><principal-award-recipient><name><surname>Zhu</surname><given-names>Changyu</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000048</institution-id><institution>American Cancer Society</institution></institution-wrap></funding-source><award-id>PF-14-066-01-TBE</award-id><principal-award-recipient><name><surname>Morris</surname><given-names>John P</given-names><suffix>4th</suffix></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Helmholtz foundation</institution></institution-wrap></funding-source><award-id>VH-NG-1114</award-id><principal-award-recipient><name><surname>Tschaharganeh</surname><given-names>Darjus F</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>C David Allis, is a co founder of Chroma Therapeutics and Constellation Pharmaceuticals and a Scientific Advisory Board member of EpiCypher..</p></fn><fn fn-type="conflict" id="conf3"><p>Scott W Lowe, is an advisor for and has equity in the following biotechnology companies: ORIC Pharmaceuticals, Faeth Therapeutics, Blueprint Medicines, Geras Bio, Mirimus Inc., and PMV Pharmaceuticals. S.W.L. also acknowledges receiving funding and research support from Agilent Technologies and Calico, for the purposes of massively parallel oligo synthesis and single-cell analytics, respectively..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments were approved by the MSKCC Institutional Animal Care and Use Committee (protocol 11-06-011). Animals were monitored for signs of ill-health by veterinary staff at the Research Animal Resource Center (RARC) at MSKCC and efforts were made to minimize suffering.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Source files of all original gels and Western Blots were provided for the following figures:Figure 1-figure supplement 2B;Figure 4-figure supplement 1A, C, D, E;Figure 5-figure supplement 2B, F, G.RNA sequencing and ChIP sequencing data files that support the findings of this study have been deposited in the Gene Expression Omnibus under the accession code GSE85055, as well as in the Dryad digital repository (doi:10.5061/dryad.7pvmcvdwm; doi:10.5061/dryad.f1vhhmh0h).All other data supporting the findings of this study will be made available upon reasonable request to the corresponding authors.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Scott W Lowe</collab></person-group><year iso-8601-date="2017">2017</year><source>Mll3 suppresses tumorigenesis by activating the Ink4a/Arf locus</source><ext-link ext-link-type="uri" xlink:href="www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85055">www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85055</ext-link><comment>NCBI Gene Expression Omnibus, GSE85055</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>M Soto-Feliciano Y</collab><collab>Zhu C</collab><collab>P Morris 4th J</collab><collab>Huang C</collab><collab>P Koche R</collab><collab>Ho Y</collab><collab>Banito A</collab><collab>Chen C</collab><collab>Shroff A</collab><collab>Tian S</collab><collab>Livshits G</collab><collab>Chen C</collab><collab>Fennell M</collab><collab>A Armstrong S</collab><collab>Allis</collab><collab>CD</collab><collab>F Tschaharganeh D</collab><collab>W Lowe S</collab></person-group><year iso-8601-date="2022">2022</year><source>Mll3 suppresses tumorigenesis by activating the Ink4a/Arf locus</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.7pvmcvdwm">https://doi.org/10.5061/dryad.7pvmcvdwm</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.7pvmcvdwm</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>M Soto-Feliciano Y</collab><collab>Zhu C</collab><collab>P Morris 4th J</collab><collab>Huang C</collab><collab>P Koche R</collab><collab>Ho Y</collab><collab>Banito A</collab><collab>Chen C</collab><collab>Shroff A</collab><collab>Tian S</collab><collab>Livshits G</collab><collab>Chen C</collab><collab>Fennell M</collab><collab>A Armstrong S</collab><collab>Allis</collab><collab>CD</collab><collab>F Tschaharganeh D</collab><collab>W Lowe S</collab></person-group><year iso-8601-date="2022">2022</year><source>MLL3 ChIP sequencing in murine and human HCC cells</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.f1vhhmh0h">https://doi.org/10.5061/dryad.f1vhhmh0h</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.f1vhhmh0h</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Ethan Cerami</collab><collab>et al</collab></person-group><year iso-8601-date="2012">2012</year><source>Cbioportal</source><ext-link ext-link-type="uri" xlink:href="www.cbioportal.org/">www.cbioportal.org/</ext-link><comment>N/A</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Jianjiong Gao</collab><collab>et al</collab></person-group><year iso-8601-date="2013">2013</year><source>Cbioportal</source><ext-link ext-link-type="uri" xlink:href="www.cbioportal.org/">www.cbioportal.org/</ext-link><comment>N/A</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-80854-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>